drugset / Trial / NCT03081169

Timing of VTE Prophylaxis in TBI

NCT03081169

Phase 4 Withdrawn Loyola University
RandomizedParallel-groupOpen-labelPrevention

Summary

This study compares the efficacy and complication rates of early (24 hours) versus late (72 hours) VTE prophylaxis administration to TBI patients. Patients in both treatment groups will be monitored for development of VTE as well as complications from bleeding after commencement of VTE prophylaxis.

Timeline

Start
2017-04-03
Primary completion
2019-08-12
Completion
2019-08-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enoxaparin sodium Other / unclassified 30 mg
Comparator Heparin Other / unclassified 5000 iu